Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020139001 - PHARMACEUTICAL COMPOSITION FOR PROMOTION OF INTRACELLULAR ATP PRODUCTION

Publication Number WO/2020/139001
Publication Date 02.07.2020
International Application No. PCT/KR2019/018567
International Filing Date 27.12.2019
IPC
C07D 305/08 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
305Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
02not condensed with other rings
04having no double bonds between ring members or between ring members and non-ring members
08with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring atoms
C07D 405/12 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
405Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
02containing two hetero rings
12linked by a chain containing hetero atoms as chain links
C07D 407/12 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
407Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/183
02containing two hetero rings
12linked by a chain containing hetero atoms as chain links
C07D 409/12 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
409Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
02containing two hetero rings
12linked by a chain containing hetero atoms as chain links
C07D 417/12 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
417Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/196
02containing two hetero rings
12linked by a chain containing hetero atoms as chain links
A61K 31/337 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
337having four-membered rings, e.g. taxol
CPC
A61K 31/337
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
337having four-membered rings, e.g. taxol
A61P 3/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
04Anorexiants; Antiobesity agents
C07D 305/08
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
305Heterocyclic compounds containing four-membered rings having one oxygen atoms as the only ring hetero atoms
02not condensed with other rings
04having no double bonds between ring members or between ring members and non-ring members
08with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring atoms
C07D 405/12
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
405Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
02containing two hetero rings
12linked by a chain containing hetero atoms as chain links
C07D 407/12
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
407Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
02containing two hetero rings
12linked by a chain containing hetero atoms as chain links
C07D 409/12
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
409Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
02containing two hetero rings
12linked by a chain containing hetero atoms as chain links
Applicants
  • 고려대학교 산학협력단 KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION [KR]/[KR]
  • 한국과학기술연구원 KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY [KR]/[KR]
Inventors
  • 서홍석 SEO, Hong Seog
  • 이용직 LEE, Yong Jik
  • 심태보 SIM, Tae Bo
  • 센굽타산디프 SENGUPTA, Sandip
  • 신인재 SHIN, Injae
  • 허우영 HUR, Wooyoung
Agents
  • 특허법인 다해 DAHAI INTERNATIONAL PATENT & LAW FIRM
Priority Data
10-2018-017064227.12.2018KR
10-2019-017603227.12.2019KR
Publication Language Korean (KO)
Filing Language Korean (KO)
Designated States
Title
(EN) PHARMACEUTICAL COMPOSITION FOR PROMOTION OF INTRACELLULAR ATP PRODUCTION
(FR) COMPOSITION PHARMACEUTIQUE POUR FAVORISER LA PRODUCTION D'ATP INTRACELLULAIRE
(KO) 세포 내 ATP 생성 촉진을 위한 약제학적 조성물
Abstract
(EN)
The present invention provides a novel aryl-substituted aminomethyloxetenyl amino alcohol derivative or a pharmaceutically acceptable salt thereof. More specifically, the derivative has an effect of promoting ATP production and as such, can be advantageously used for preventing or treating a disease requiring an increased level of ATP for therapy thereof.
(FR)
La présente invention concerne un nouveau dérivé amino-alcool aminométhyloxétényle substitué par un groupement aryle ou un sel pharmaceutiquement acceptable de celui-ci. Plus précisément, ledit dérivé a pour effet de favoriser la production d'adénosine triphosphate (ATP) et, en tant que tel, peut être avantageusement utilisé pour prévenir ou traiter une maladie nécessitant un niveau accru d'ATP pour la thérapie de celle-ci.
(KO)
본 발명은 신규한 아릴 치환된 아미노메틸옥세테닐 아미노 알코올 유도체 또는 이의 약학적으로 허용 가능한 염을 제공한다. 보다 상세하게는, 상기 유도체에는 ATP 생성을 촉진하는 효과가 있으므로, 상기 유도체는 ATP 증가가 필요한 질환의 예방 또는 치료에 유용하게 사용될 수 있다.
Also published as
Latest bibliographic data on file with the International Bureau